Newsletter Subject

FDA to Usher in New Era January 12, 2018 [Video]

From

jeffclarktrader.com

Email Address

feedback@exct.jeffclarktrader.com

Sent On

Sun, Dec 31, 2017 03:01 PM

Email Preheader Text

Editor's Note: Have you ever seen a stock skyrocket right after an FDA announcement, and wondered wh

[Jeff Clark Trader] Editor's Note: Have you ever seen a stock skyrocket right after an FDA announcement, and wondered what it would take to know about the announcement ahead of time? Silicon Valley insider, Jeff Brown, has the scoop on that very situation. You can read the details in the following note. --------------------------------------------------------------- Dear Reader, Our chief technology analyst just sent me an urgent note... I won't post the whole thing here. But basically, he told me to circle a key day on my January calendar. In January, he believes the FDA should greenlight a breakthrough that "will change everything you know about medicine, biotech, and your own life on this planet," he said. He also said it will create a $1 trillion-dollar industry (35,000% potential growth) in very little time. That's 7 times bigger than the entire market for cancer drugs! Bold words, I know. And if it were anyone else, I'd be inclined to dismiss them as hyperbole. But this guy has done 89 deals in this space... and he spotted the S&P's top-performing stock last year (up 500%+ and counting). I've posted this gentleman's presentation online. You can access it [here](. But please note: Because of the time-sensitive nature of this opportunity, it will only remain online until January 12. Best regards, Will Bonner Publisher, Bonner & Partners P.S. 3 tiny American companies own ALL the key patents on this breakthrough. You can access all the [details here](. © Jeff Clark Trader. All Rights Reserved. 55 NE 5th Avenue, Delray Beach, FL 33483 No longer wish to receive special offers from us? [Click here for options.](

Marketing emails from jeffclarktrader.com

View More
Sent On

06/12/2024

Sent On

04/12/2024

Sent On

03/12/2024

Sent On

29/11/2024

Sent On

27/11/2024

Sent On

26/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.